SCHEMBL10072258

SCHEMBL10072258

O=C(N/N=C/Cc1ccccc1)C(Cl)(Cl)Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
MMP2 P08253 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 4/20 0.38
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
ATM Q13315 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2D6 P10635 1/20 0.36
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938561 0.81 ALDH1A1 (0.59) ALDH1A1MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL23253782 0.78 ALDH1A1 (0.60) ALDH1A1MMP2SMN1; SMN2KMT2AMEN1
Phenylmethylsemicarbazone SCHEMBL31006435 0.78 ALDH1A1 (0.56) ALDH1A1MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL11302626 0.77 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL17541218 0.77 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL11293827 0.75 ALDH1A1 (0.69) ALDH1A1MMP2SMN1; SMN2KMT2APOLB
SCHEMBL28909466 0.74 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL14938457 0.73 ALDH1A1 (0.51) ALDH1A1MMP2SMN1; SMN2HTTPOLB
SCHEMBL17666943 0.71 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2KMT2AHTTPOLB
SCHEMBL17666941 0.71 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2KMT2AHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193192-B2 Heterocyclic FXR binding compounds PHENEX PHARMACEUTICALS AG (DE) 2012-06-05 US disclosed
US-20100210660-A1 Heterocyclic FXR Binding Compounds PHENEX PHARMACEUTICALS AG (DE) 2010-08-19 US disclosed
US-20100184809-A1 Heterocyclic FXR Binding Compounds PHENEX PHARMACEUTICALS AG (DE) 2010-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210660-A1 Heterocyclic FXR Binding Compounds NR1H4, NR1I3, NR1I2 ALDH1A1 3529/4885MMP2 4696/4885SMN1; SMN2 4816/4885
US-20100184809-A1 Heterocyclic FXR Binding Compounds NR1H4, NR1H2, NR1H3 ALDH1A1 3095/4885MMP2 4825/4885SMN1; SMN2 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.